Daidzein but not other phytoestrogens preserves bone architecture in ovariectomized female rats in vivo.
Ovariectomy of immature female rats, results in significant decrease of trabecular bone volume and in cortical bone thickness. Previously, we found that estradiol-17beta (E(2)) restored bone structure of ovariectomized (Ovx) female rats to values obtained in intact sham-operated female rats. E(2) also selectively stimulated creatine kinase (CK) specific activity a hormonal-genomic activity marker. In the present study, we compared the effects of E(2) and the phytoestrogens: daidzein (D), biochainin A (BA), genistein (G), carboxy-derivative of BA (cBA), and the SERM raloxifene (Ral) in Ovx, on both histological changes of bones and CK, when administered in multiple daily injections for 2.5 months. Bone from Ovx rats, showed significant disrupted architecture of the growth plate, with fewer proliferative cells and less chondroblasts. The metaphysis underneath the growth plate, contained less trabeculae but a significant increased number of adipocytes in the bone marrow. D like E(2) and Ral but not G, BA, or cBA, restored the morphology of the tibiae, similar to that of control sham-operated animals; the bony trabeculeae observed in the primary spongiosa was thicker, with almost no adipocytes in bone marrow. Ovariectomy resulted also in reduced CK, which in both epiphysis and diaphysis was stimulated by all estrogenic compounds tested. In summary, only D stimulated skeletal tissues growth and differentiation as effectively as E(2) or Ral, suggesting that under our experimental conditions, D is more effective in reversing menopausal changes than any of the other isolated phytoestrogens which cannot be considered as one entity.
Somjen
D
D
Institute of Endocrinology, Metabolism and Hypertension, Tel-Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, Israel. dalias@tasmc.health.gov.il
Katzburg
S
S
Kohen
F
F
Gayer
B
B
Livne
E
E
D017667:Adipocytes / Q000473:pathology; D000818:Animals; D001853:Bone Marrow / Q000473:pathology; D001842:Bone and Bones / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D003402:Creatine Kinase / Q000378:metabolism*; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D019833:Genistein / Q000008:administration & dosage / Q000494:pharmacology; D006132:Growth Plate / Q000187:drug effects / Q000473:pathology; D007529:Isoflavones / Q000008:administration & dosage / Q000494:pharmacology*; D010052:Ovariectomy; D048789:Phytoestrogens / Q000008:administration & dosage / Q000494:pharmacology*; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013977:Tibia / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D014129:Trabecular Meshwork / Q000187:drug effects / Q000201:enzymology / Q000473:pathology
D007529:Isoflavones; D048789:Phytoestrogens; D020849:Raloxifene Hydrochloride; D004958:Estradiol; C004742:daidzein; D019833:Genistein; D003402:Creatine Kinase; C004541:biochanin A